InnovAge (OTCMKTS:INNV) Sets New 52-Week High – Should You Buy?

InnovAge Holding Corp. (OTCMKTS:INNV)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $9.19 and last traded at $8.92, with a volume of 477187 shares changing hands. The stock had previously closed at $8.16.

InnovAge Trading Down 0.2%

The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.57 and a current ratio of 1.57. The firm has a market capitalization of $1.21 billion, a P/E ratio of -28.71 and a beta of 0.57. The firm has a 50 day simple moving average of $6.49 and a two-hundred day simple moving average of $5.38.

InnovAge Company Profile

InnovAge Holdings, Inc, trading under the ticker INNV on the OTC Markets, is a specialized health care services company focused on delivering comprehensive geriatric care through the Program of All-Inclusive Care for the Elderly (PACE). The company’s model is designed to provide integrated medical and social services for seniors who qualify for both Medicare and Medicaid, with an emphasis on allowing participants to remain in their homes and communities for as long as possible.

InnovAge’s core offerings include primary medical care, prescription drug coverage, rehabilitative therapies, transportation, nutritional counseling and home-based support services.